Physician profile
Timothy Browne
NPI 1740866136
$1,349.23
in general payments reported to CMS, 2019-2025
14 companies · $570 in 2025
The $570 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $119 · 2023: $285 · 2024: $376 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,162 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,162.12 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $217.75 | 2022-2025 | Imfinzi |
| Bolton Medical INC | $198.26 | 2025 | Thoraflex Hybrid, Relay Thoracic Stent-Graft With Plus Delivery System |
| Medtronic, INC. | $198.25 | 2023-2024 | Endurant Iis, Signia |
| Abbvie INC. | $185.96 | 2023-2025 | Alloderm |
| Octapharma USA, INC. | $114.87 | 2025 | Fibryga |
| Kci USA, INC. | $97.55 | 2022-2023 | Prevena, V.A.C. Veraflo, Abthera |
| Axogen | $88.42 | 2025 | |
| Ethicon US, LLC | $67.67 | 2024 | Echelon; Endopath, Echelon Flex |
| Stryker Corporation | $52.25 | 2022-2023 | Spy-Phi System |
| Allergan, INC. | $42.01 | 2022 | |
| Teleflex LLC | $25.09 | 2025 | Quikclot |
| Merck Sharp & Dohme LLC | $24.10 | 2024 | Keytruda |
| E.R. Squibb & Sons, L.L.C. | $23.52 | 2023 | Camzyos |
| Purdue Pharma L.P. | $13.53 | 2024 | Nalmefene Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Browne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.